Five commercial kits for the assay of lipoprotein(a) were investigated and two of these, the Immuno Enzyquick and Biopool TintElize, both enzyme-linked immunoassays, were studied in detail. Whilst there was a strong correlation between the results obtained using the two methods there was a significant difference between the absolute values. In view of its higher precision at low levels and robust performance, the Enzyquick kit (Immuno Ltd) was selected for use in this laboratory. 20 
Lipoprotein(a) (Lp(a)) represents a class of lipoprotein particles with physical and chemical properties similar to those of low density lipoproteins (LDL). The major protein constituent of both types of particle is apoprotein BlOO (apoB100). However, Lp(a) also contains a highly glycosylated protein moiety, apoprotein(a) (apo(a)), which is attached to apoB by a disulphide bridge.l Apo(a) has been shown to have a considerable degree of homology with human pla~minogen.~-~ Since its discovery by Berg5 in 1963, numerous studies have revealed a strong correlation between elevated plasma concentrations of Lp(a) and cardiovascular disease.6-8 Lp(a) is reported as being present in the plasma of all subjects with apoBg-I0 and there is evidence that high levels of Lp(a) in plasma represent an independent risk factor for coronary heart disease (CHD)."-I3 Armstrong et al. I2 report a doubling of risk for CHD at Lp(a) concentrations above 30 mg/dL and a five-fold increase in risk when both LDL and Lp(a) levels are elevated. In spite of the fact that LDL and Lp(a) both contain apoB as a major apoprotein, their concentrations do not show co-variance. I4-l5 Thus diets that lower LDL levels do not affect Lp(a) 14 of the order of 30% in hyperlipidaemic subjects treated with nicotinic acid.Ig
In view of the fact that Lp(a) levels are unaffected by diet and most drugs it is not envisaged that serum Lp(a) levels should be offered as a screening test; but rather should be measured in those individuals who are regarded as being at high risk of developing CHD. For example, individuals with high levels of LDL who are resistant to lipid-lowering therapy and subjects with familial hypercholesterolaemia who have as a group increased incidence of CHD. Comparing two groups of familial hypercholesterolaemics with and without CHD Houlston et aL7 found significantly higher Lp(a) levels in the diseased group; thus even in this high risk group, knowledge of Lp(a) levels improves the ability to evaluate the CHD risk. High risk subjects who were shown to have high levels of Lp(a) might then be considered for more aggressive treatment to reduce other risk factors, or possibly treatment with nicotinic acid to reduce Lp(a) levels. However, it has yet to be demonstrated that lowering high plasma Lp(a) levels beneficially influences the progression of coronary atherosclerosis.
In view of these findings it was decided that a plasma Lp(a) assay should be made available as a specialist test in our laboratory. A variety of commercially available assay systems was screened: radial immunodiffusion (RID) plates, gels for Laurell rockets, an immunoradiometric assay (IRMA) and two enzyme-linked immunoassays (ELISA). Presentation of materials, ease 359 of use and time required for a typical assay were reviewed and precision compared. It was not possible to consider accuracy as standardization of Lp(a) and the other apolipoprotein assays is a problem, there being no recognized primary standards available.
MATERIALS AND METHODS

Patients' samples
Samples were obtained from patients undergoing LDL apheresis, patients undergoing coronary angiography and normal laboratory volunteers. Blood was collected into 10 mL potassium EDTA tubes (final concentration potassium EDTA 1 mg/mL). After separation plasma was stored at -20 "C until assay.
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Radial immunodiffusion
The Immuno RID kit contains three, eight-well plates. Thirty-two samples were estimated on eight plates, with three standards and one control on each. Five microlitre samples were applied and when these had diffused completely into the agarose the wells were filled with 15% Dextran T-70 solution and the plates incubated at room temperature for 7 days. They were then washed with 0.9% saline and the precipitin rings visualized by staining with Coomassie blue. The diameters of the precipitin rings were measured and the sample and control values read from the standard curve.
Laurell rockets
The Immuno electroimmunodiffusion kit contains three, 13-well gel foils, buffer concentrate, standard, stain and destain. Forty-five samples were run on five gels using the Immuno Radiophor electrophoresis chamber at 30 mA, 60 V per gel for 3 h. After washing with 0.9% saline gels were stained and the height of the rockets measured. Sample and control values were read from the standard curve.
Irnmunoradiometric assay
The Pharmacia IRMA kit contains reagents for 100 tubes, 42 tests plus one standard curve in duplicate. Forty patient samples were incubated for 1 h with 50pL of pre-treatment solution, followed by the addition of 2 mL of diluent. To 50 pL of the diluted sample were added, 50 pL of anti-ap~(a)-'~'I and 50 pL of antibody suspension. After shaking the mixture was incubated for 1 h, 2 mL of decanting solution added and the tubes centrifuged at 1500 g for 10 min. The supernatant was decanted and the radioactivity remaining in the pellet counted in a y-counter.
Enzyme-linked irnmunoassays
The initial screening also involved measuring the same 40 samples in two Immuno and two Biopool ELISA kits. Plate washing was performed manually and plates were read using a Dynatech MR5OOO microplate reader (Dynatech Laboratories Ltd, Billinghurst, UK). The Immuno kit contains lyophilized standards and reagents for 40 tests and one standard curve in duplicate. Standards were reconstituted and treated in the same manner as samples. Ten microlitre samples were diluted 1500 and 200 pL aliquots of these dilutions were added to test wells. Plates were incubated for 1 h at room temperature then washed five times with buffer followed by the addition of 200pL of second antibody conjugate. A further 1 h incubation and washing as above was followed by addition of substrate. After 20 min incubation the reaction was stopped by addition of 50pL 2M H,SO,.
Plates were read at 450nm and sample values estimated from the standard curve.
The Biopool kit contains reagents for 42 tests in duplicate. Single standards are already in place in the first eight wells of the microtitre plate. Twenty microlitre samples were diluted with 1 mL buffer, 20pL of this solution was then diluted with a further 1 mL buffer. The plate was reconstituted by the addition of 100 pL of buffer to each well. After 1 min shaking, 20 pL of diluted samples was added to test wells and the plate incubated at room temperature, with shaking on a dedicated microtitre plate shaker at 500 rpm for 2 h. Fifty microlitres of reconstituted conjugate were then added to each well and the plate incubated as before for 1 h. After washing five times, 200 pL of reconstituted substrate was added to each well and the reaction stopped after 10 min by the addition of 50 pL 3M H,SO, to each well. The plate was then shaken for a further 5 min before being read at 490 nm, and sample values estimated from the standard curve.
Comparison of ELISA methods
On the basis of their performance in the initial screening the two ELISA methods were chosen for detailed consideration. The study format was designed to maximize the yield of statistically useful data. Ten kits from each manufacturer were included and all tests and controls were run in duplicate. Three quality control plasmas obtained from laboratory volunteers with low, medium and high levels of Lp(a) were used to measure imprecision. The control plasma at each level was obtained from a single volunteer on a single occasion. Controls were treated in all respects in the same way as patient samples: stored at -20 "C for periods of up to 6 months with further aliquots stored at -70 "C. No change in apparent Lp(a) concentrations was detected following a single freeze thaw cycle, but repeated freeze thaw cycles resulted in a reduction in apparent concentration. Within-batch imprecision was estimated by assaying 13 samples of each of the three controls on one plate. The same controls were included at random positions in every batch to determine between-batch imprecision. The correlation between the two methods was obtained by performing assays in parallel; that is a series of 40 samples was assayed using both kits on the same day.
All experimental work was carried out by a single operator.
RESULTS AND DISCUSSION
Three kits were eliminated from detailed examination following the initial screening, the RID and Laurell rocket methods and the IRMA. The RID method is very slow requiring a 7 day incubation.
Whilst the kit has the advantage that no specialized equipment is required and might be useful for screening small numbers of samples, the method is at best semi-quantitative.
A Radiophor electrophoresis chamber (Immuno Ltd) is required to run the Laurell rocket gels.
While standards and controls ran very well, patient samples gave less well-defined rockets The results obtained using the Pharmacia IRMA were generally in close agreement with those obtained using the ELISA methods, except for those samples with very high levels of Lp(a), greater than 80 mg/dL, where agreement was poor. In view of this and the poorer between.
batch precision of the IRMA in our hands the kit was not pursued further (mean 321 u/L; SD 31 u/L), although others have used it with satisfactory results.
Both the ELISA kits are simple and straightforward to use, and each has its advantages. Immuno's Enzyquick system involves a single step pre-dilution, does not require a dedicated microtitre plate shaker and can be used to run small numbers of tests; although this, of course, would increase costs per test. Biopool's coloured sample dilution buffer facilitates the addition of sample to test wells, the method involves only one wash step and the 96-well plate is easily handled in washing. These differences are summarized in Table 1 .
In both kits the second antibody is conjugated to peroxidase. However, different substrates are employed for the colour reaction. The Biopool assay uses 1,2-phenyIenediamine, a compound known to be carcinogenic, whereas the substrate in the Immuno kit is 3,3,5,5-tetramethylbenzidine, a compound not listed as a carcinogen. While the Biopool substrate is adequately labelled with the appropriate warning, both laboratory safety, which is currently very much to the fore in view of the recent Control of Substances Hazardous to Health (COSHH) legislation, and the possible future costs of disposal must be considered.
Performance of both ELISA methods was satisfactory. The data for intra-and inter-assay coefficients of variation are shown in Table 2 . Results from two of the Biopool plates were Inter-assay rejected because the duplicates were poor and in one case the standard curve was unacceptable. One of the Immuno plates gave low values for the high control (54 mg/dL, range 63-77 mg/dL). However, the patient data obtained were included in the statistical analysis and the control value in the coefficient of variation.
Response error relationships (RERs) were derived for the two kits after the method described by EkinsZ0 by accumulating the standard deviations in absorbance measurements in duplicate analyses (Figs 1 and 2) . In essence, the RER minimizes the effects of between sample variances and gives an estimate of the standard deviation of duplicates likely to be encountered for any given measurement of absorbance. A precision dose profile can be calculated:z1 the error at a given absorbance value is obtained by substituting the value into the line equation of the least squares fit of the RER. This value can then be used with the slope of the calibration curve at that point to calculate the relative error. The values obtained for typical calibration curves are given in Table  3 . While the relative errors in the two methods were similar over most of the measuring range, they were greater in the Biopool system at low concentrations; the range, in fact, where values from most subjects fall. The population distribution of Lp(a) levels was highly skewed, as indicated by the box plots in Fig. 3 . Accordingly a square root transformation was applied to normalize data for statistical analysis.
There was a statistically significant difference between the results obtained by the t w o methods by paired Student's t-test (P< 0-Oool). However, there was a good correlation coefficient of 0.974 (Fig. 4) . The least squares regression line fitted to the untransformed data ( Fig. 5 ) had an intercept which was not significantly different from zero (-0.64; 95% CI -2.OO-+0-72), with a gradient of 0-86 (95% CI 0.82-0.90), indicating 
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Response error relationships of the ELISA kits
Relative Relative that while there was n o bias between the two methods, there was a difference in response, with the Biopool kit registering value 86% of those by the lmmuno kit. The two kits quote different measuring ranges, 5-80mg/dL in the case of Imrnuno and 0-60 mg/dL in the case of Biopool. In practice the actual measuring ranges of the two systems are very similar (Figs 4 and 5 ) . Samples with values beyond the measuring range of the kits were estimated by dilution. Dilution of samples with Lp(a) concentrations in the range 20-60 mg/dL with either sample dilution buffer or Lp(a) negative plasma gave results with 6% of the values obtained with neat plasma.
To determine whether there was any crossreactivity with apoB, plasma apoB and LDL apoB were measured on patients' samples. No relationship was found between apoB levels and measured Lp(a) concentrations, nor did purified LDL crossreact in either kit. 
CONCLUSION
Both ELISA Lp(a) kits performed well in this analysis, although there were differences as described above. In view of the better precision at low levels, the robust performance of the assay and health and safety considerations the Immuno Enzyquick kit has been selected for use in this laboratory.
